Karabuk University   Report issue

Academic/Hospital
Founded: Karabuk Turkey (2007)

Organization Overview

First Clinical Trial
2018
NCT03779516
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Karabuk University | Karabuk University Training and Research Hospital

Active Ingredients

Drugs in Other Trials (2)

chlorhexidine (hibitane) (1 trial)

lidocaine (xylocaine) (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 4
  • # of Trial APIs: 2